Mild-to-moderate Ulcerative Colitis induction therapy: budesonide (CORE studies) Once-daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study William J Sandborn, Simon Travis, Luigi Moro , Richard Jones, Theres Gautille, Robert Bagin , Michael Huang, Phil Yeung, E David Ballard Background & aims: Budesonide is a corticosteroid with minimal systemic corticosteroid activity ..

Read more